Stock listing
Harrow, Inc.
Selected listing: 3IP · FWB · EUR · DE
Harrow, Inc. (Frankfurt:3IP), Health Technology. Latest release Oct 5, 2026: Harrow Closes Acquisition of TYRVAYA®.
- Ticker
- Frankfurt:3IP
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- Frankfurt
- Currency
- EUR
About Harrow, Inc.
The company focuses on the development and commercialization of innovative pharmaceutical products. Harrow aims to enhance patient care through its specialized offerings in the healthcare sector.
Latest news from Harrow, Inc.
Harrow Closes Acquisition of TYRVAYA®
October 4, 2026
Harrow Closes Acquisition of TYRVAYA®
October 5, 2026
Harrow Ophthalmic Portfolio Highlighted in 15 Scientific Presentations at AAOpt and AAO
September 29, 2026
Harrow Ophthalmic Portfolio Highlighted in 15 Scientific Presentations at AAOpt and AAO
September 30, 2026
Harrow to Participate in Three Investor Conferences in September
September 1, 2026